Wordt geladen...
Acid-induced aggregation propensity of nivolumab is dependent on the Fc
Nivolumab, an anti-programmed death (PD)1 IgG(4) antibody, has shown notable success as a cancer treatment. Here, we report that nivolumab was susceptible to aggregation during manufacturing, particularly in routine purification steps. Our experimental results showed that exposure to low pH caused a...
Bewaard in:
| Gepubliceerd in: | MAbs |
|---|---|
| Hoofdauteurs: | , , , , , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Taylor & Francis
2016
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4968106/ https://ncbi.nlm.nih.gov/pubmed/27310175 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/19420862.2016.1197443 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|